Roseville, MN, United States of America

Vuong N Trieu

This inventor holds 4 USPTO granted patents. Top assignees: Parker Hughes Institute, Hughes Institute, Wayne Hughes Institute. Active years: 2000-2002.


% Patents Active = 50.0

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2000-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Vuong N Trieu

Introduction

Vuong N Trieu is an accomplished inventor based in Roseville, MN (US). He has made significant contributions to the field of dietary supplements, particularly in the area of lipid-lowering compositions. With a total of four patents to his name, his work focuses on innovative methods for managing cholesterol levels.

Latest Patents

Among his latest patents are two notable inventions: the "Lipid lowering quinazoline dietary supplement composition" and the "Lipid-lowering quinazoline derivative." Both patents describe a novel carbonyl-substituted quinazoline, specifically 4-(3′-bromobenzoyl)-6,7-dimethoxyquinazoline (WHI-P164). These inventions detail methods for lowering blood cholesterol, including the reduction of total cholesterol and LDL-cholesterol levels through the administration of these carbonyl quinazolines and their compositions.

Career Highlights

Vuong N Trieu has worked with reputable organizations such as the Parker Hughes Institute and the Wayne Hughes Institute. His experience in these institutions has allowed him to further develop his innovative ideas and contribute to advancements in health-related research.

Collaborations

Some of his notable coworkers include Fatih M Uckun and Xing-Ping Liu. Their collaborative efforts have likely played a role in the development of his patented inventions.

Conclusion

Vuong N Trieu's work exemplifies the impact of innovation in the field of dietary supplements. His patents reflect a commitment to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…